Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Apr 17;11:459. doi: 10.3389/fphar.2020.00459

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2020 Wang, Ye and Wang

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

The effects of the SM, TMZ, and control treatments on CTCM-s in patients with HF. (A) CTCM-s at baseline and after 7 days of treatment in the SM, TMZ, and control groups; *P <0.01 vs. the baseline of SM; ^#P < 0.01 vs. the baseline of TMZ; the control group (7 days), P < 0.01 vs. the baseline of control; *P < 0.01 and ^#P > 0.05 compared with the control group (7 days), *P < 0.05 compared with the TMZ group (7 days); (B) CTCM-s in the SM, TMZ, and control groups after 7 days; *P < 0.01 or ^#P > 0.05 vs. the control group (7 days); *P < 0.05 vs. the TMZ group (7 days). CTCM-s ratio= (baseline-7 days)/baseline.